IntMTQ

IntMTQ integrates mRNA quantification data from RNA-Seq, NanoString's nCounter, and exon-array platforms to improve transcript isoform abundance estimation and mitigate sampling bias and ambiguous read origins for more accurate isoform-level analysis.

Key Features:

• Integration Across Platforms: Combines isoform expression measurements from RNA-Seq, NanoString's nCounter, and exon-array platforms to leverage complementary signals across technologies.
• Improved Isoform Expression Estimation: Incorporates non-RNA-Seq mRNA expression data to increase the precision of RNA-Seq-based isoform quantification.
• Enhanced Downstream Analysis: Produces consistent isoform expression profiles that improve molecular features for clustering and classification of cancer cell lines compared with RNA-Seq-only baselines.
• Validation through Experimental Assessment: Performance was evaluated using three experimental tasks across mRNA quantification platforms and an independent RT-qPCR experiment confirmed improved transcript quantification for a set of genes in cancer cell lines.
• Application in Large-Scale Studies: Enables integrative analyses of datasets combining RNA-Seq and array-based platforms, such as TCGA, to support robust disease phenotype prediction.

Scientific Applications:

• Transcriptome Isoform Quantification in Cancer Research: Provides precise isoform-level expression estimates for studying molecular mechanisms in cancer.
• Molecular Signature Discovery and Phenotype Prediction: Supplies improved isoform features for disease phenotype prediction in large-scale studies including TCGA.
• Clustering and Classification of Cancer Cell Lines: Enhances accuracy of clustering and classification tasks using isoform-level expression data.

Methodology:

IntMTQ integrates isoform expression data from multiple mRNA quantification platforms (RNA-Seq, NanoString nCounter, exon-array) using a computational model that harmonizes inputs to estimate transcript isoform abundances.